GABRIEL ASANTE-ODAME: Open Payments
NPI 1275209405 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 18 payments from 5 companies in 2025. Trend: 2023 $105 · 2024 $745 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $151 |
| Alkermes, Inc. | 3 | $150 |
| Teva Pharmaceuticals USA, Inc. | 2 | $137 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: CAPLYTA, AUSTEDO XR, LYBALVI, QULIPTA, VRAYLAR, ARISTADA, UBRELVY, Qelbree.
Industry payments across NY — which companies pay providers there.
